Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aon PLC (AON) vs Novavax Inc (NVAX) Price & Performance

Novavax IncTrade

Price performance (Past 24H)

Key statistics

Aon PLC vs Novavax Inc — how do they compare? Aon PLC trades at $356.48 (market cap $75.61B), while Novavax Inc trades at $7.95 (market cap $1.31B). The key difference: Aon PLC is far larger — about 57.7× Novavax Inc's market cap, and Aon PLC pays a 0.92% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

AONNVAX
Market Cap
$75.61B$1.31B
Sector
FinancialsHealth
52-Week High
$381.26$11.19
52-Week Low
$308.22$6.22
Enterprise Value
$90.22B$889.30M
Dividend Yield
0.92%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aon PLC

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.

The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aon PLC

Aon is a leading global provider of insurance and reinsurance brokerage and human resource solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in 120 countries around the world.

Read more on AON

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX